AstraZeneca raises 35% sale of new drugs in 2020
AstraZeneca’s new drug sales increased 35% year-on-year in 2020, to $ 13.359 million. In fact, that result had a boost in emerging markets, where new
AstraZeneca’s new drug sales increased 35% year-on-year in 2020, to $ 13.359 million. In fact, that result had a boost in emerging markets, where new
Las ventas de nuevos medicamentos de AstraZeneca aumentaron 35% interanual en 2020, a 13,359 millones de dólares. De hecho, ese resultado tuvo un impulso en
AstraZeneca’s new drug sales increased 35% year-on-year in 2020, to $ 13.359 million. In fact, that result had a boost in emerging markets, where new
Las ventas de nuevos medicamentos de AstraZeneca aumentaron 35% interanual en 2020, a 13,359 millones de dólares. De hecho, ese resultado tuvo un impulso en
info@opportimes.com